Company CVAbout Abbott India Ltd. 
Abbott India Ltd.
Large Cap
Pharmaceuticals & Drugs
Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily within India.
Company Coordinates
Company Details
Unit No 3 Corporate Park, Sion Trombay Road Chembur Mumbai Maharashtra : 400071
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 21.25 Cr
Number of Shares
2.12 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Sep-2011
2.12
21.25
7574062
10
Amalgamation
07-Sep-2011
2.12
21.25
7574062
10
Amalgamation
14-Aug-2008
1.37
13.68
-797500
10
Buy Back of Shares
14-Aug-2008
1.37
13.68
-797500
10
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 34 Schemes (7.77%)
FIIs
Held by 12 FIIs (0.16%)
Promoter with highest holding
Abbott Capital India Limited (50.44%)
Highest Public shareholder
Sbi Long Term Advantage Fund (2.76%)
Individual Investors Holdings
13.59%
Board of Directors
Management
Designation
Remuneration
Munir Shaikh
Chairman (Non-Executive)
31.0 lacs
Kaiyomarz Marfatia
Non Executive Director
23.0 lacs
Ambati Venu
Non Executive Director
0
Anisha Motwani
Independent Director
30.0 lacs
Sudarshan Jain
Independent Director
28.0 lacs
Shalini Kamath
Independent Director
30.0 lacs
Sabina Ewing
Non Executive Director
0
Vivek Vasudev Kamath
Managing Director
6.43 cr
Mahadeo Karnik
Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Other (Purchase)
2350.36
0%
Other (Purchase)
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Injectables
1,507.14
40.97%
Tablets
1,421.77
38.65%
Liquids
512.56
13.93%
Injectables
Injectables
Tablets
Tablets
Liquids
Liquids
Stock DNARevenue and Profits:
Net Sales:
1,614 Cr
(Quarterly Results - Dec 2024)
Net Profit:
361 Cr
Pharmaceuticals & Drugs
INR 62,762 Cr (Large Cap)
46.00
33
1.41%
-0.30
37.90%
17.53
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
